us

Lotus Bio-Tech Development LBTD Stock

$0.01   0.000000%
Add to favorites
Market Cap
$6.71M
LOW - HIGH [24H]
$0.01 - $0.01
VOLUME [24H]
$20.00
P/E Ratio
0
Earnings per share
-$0.02
ISIN
US54570R1077

Lotus Bio-Tech Development Price Chart

Sorry, that's all we've gotfor now...

Lotus Bio-Tech Development LBTD Financial and Trading Overview

Lotus Bio-Tech Development stock price 0.0100 USD
Previous Close 0.01 USD
Open 0.01 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.01 - 0.01 USD
52 Week Range 0.01 - 0.01 USD
Volume 20 USD
Avg. Volume 0 USD
Market Cap 6.71M USD
Beta (5Y Monthly) 1.898
PE Ratio (TTM) N/A
EPS (TTM) -0.02 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

LBTD Valuation Measures

Enterprise Value 17.47K USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Lotus Bio-Tech Development Stock Price History

Beta (5Y Monthly) 1.898
52-Week Change 0%
S&P500 52-Week Change 15.77%
52 Week High 0.01 USD
52 Week Low 0.01 USD
50-Day Moving Average 0.01 USD
200-Day Moving Average 0.01 USD

LBTD Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 670.63M
Float 249.08M
Short Ratio N/A
% Held by Insiders 60.40%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor 30:1

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2017
Most Recent Quarter (mrq) December 31, 2017
Next Fiscal Year End March 31, 2018

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -421.29%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -12881 USD
Diluted EPS (ttm) -0.02
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1 USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 16.69K USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0
Book Value Per Share (mrq) 0

Cash Flow Statement

Operating Cash Flow (ttm) 263 USD
Levered Free Cash Flow (ttm) -72313 USD

Profile of Lotus Bio-Tech Development

Country United States
State BC
City Port Coquitlam
Address 2559 Parkview Lane
ZIP V3c6m1
Phone 778 814 7729
Website N/A
Industry Agricultural Inputs
Sector(s) Basic Materials
Full Time Employees N/A

Lotus Bio-Technology Development Corp. does not have significant operations. The company intends to seek opportunities in the Organic and Bio-technology space. Previously, it is engaged in refining organic materials, and production of natural consumer related products. The company was formerly known as Starflick.com and changed its name to Lotus Bio-Technology Development Corp. in April 2016. Lotus Bio-Technology Development Corp. was incorporated in 2011 and is based in Port Coquitlam, Canada.

Q&A For Lotus Bio-Tech Development Stock

What is a current LBTD stock price?

Lotus Bio-Tech Development LBTD stock price today per share is 0.0100 USD.

How to purchase Lotus Bio-Tech Development stock?

You can buy LBTD shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Lotus Bio-Tech Development?

The stock symbol or ticker of Lotus Bio-Tech Development is LBTD.

Which industry does the Lotus Bio-Tech Development company belong to?

The Lotus Bio-Tech Development industry is Agricultural Inputs.

How many shares does Lotus Bio-Tech Development have in circulation?

The max supply of Lotus Bio-Tech Development shares is 670.63M.

What is Lotus Bio-Tech Development Price to Earnings Ratio (PE Ratio)?

Lotus Bio-Tech Development PE Ratio is now.

What was Lotus Bio-Tech Development earnings per share over the trailing 12 months (TTM)?

Lotus Bio-Tech Development EPS is -0.02 USD over the trailing 12 months.

Which sector does the Lotus Bio-Tech Development company belong to?

The Lotus Bio-Tech Development sector is Basic Materials.

$2.78T
Total marketcap
$676.98T
Total volume
BTC 59.06%   •   ETH 10.87%
Dominance
Select currency